FDA Clearance Tracker · K242585
Cystatin C
Last checked: Nov 19, 2026Latest source record: May 16, 2025 (this decision)Source: openFDAMethods & limitations
Decided
May 16, 2025
Substantially Equivalent
Time to decision
259 days
Received Aug 30, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K242585
- Device name
- Cystatin C
- Applicant
- SENTINEL CH. SpA
- Applicant location
- Milan (Mi), IT
- Received
- Aug 30, 2024
- Decided
- May 16, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Cystatin C (NDY)
- Device class
- Class II
- Regulation
- 21 CFR 862.1225
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NDY. The earliest in FDA's data is K003503, decided Mar 13, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K242585
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for SENTINEL CH. SpA
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Lp(a) Ultra510(k)
K211058 · Decided Dec 22, 2022 · 622 days after receipt
Device type: Lipoprotein, Low-Density, Antigen, Antiserum, Control (DFC) · Laboratory Medicine & Pathology
- Albumin BCP510(k)
K193001 · Decided Dec 19, 2019 · 52 days after receipt
Device type: Bromcresol Purple Dye-Binding, Albumin (CJW) · Laboratory Medicine & Pathology
- CRP Vario510(k)
K192118 · Decided Nov 8, 2019 · 94 days after receipt
Device type: C-Reactive Protein, Antigen, Antiserum, And Control (DCK) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.